SSE Ticker: 688358

Chison Healthcare Technologies Co., Ltd.

祥生医疗

Authorized Representative: 莫善珏

Board: Star Market

Industry Classification: Biomedicine

Xiangsheng Medical (688358.SH) granted 163,800 restricted shares at the price of 24 yuan per share

Post date May 10, 2022 — 23:23 Post Lock

Xiangsheng Medical (688358): Xiangsheng Medical's 2021 Restricted Stock Incentive Plan Reserves List of Incentive Objects CFi.CN Zhongcai Network

Post date May 10, 2022 — 20:27 Post Lock

Xiangsheng Medical (688358): Resolution of the Twelfth Meeting of the Second Board of Directors of Xiangsheng Medical CFi.CN Zhongcai Network

Post date May 10, 2022 — 20:27 Post Lock

Xiangsheng Medical (688358): Xiangsheng Medical Supervisory Committee's Verification Opinions on the Company's 2021 Restricted Stock Incentive Plan Reserved to Grant the List of Incentive Objects CFi.CN Zhongcai Network

Post date May 10, 2022 — 20:27 Post Lock

Xiangsheng Medical (688358): Independent Opinions of Xiangsheng Medical Independent Directors on the Relevant Resolutions of the Twelfth Meeting of the Second Board of Directors- CFi.CN Zhongcai Network

Post date May 10, 2022 — 20:27 Post Lock

Xiangsheng Medical (688358): Legal Opinion of Shanghai KONE Law Firm on the Grant of Partial Restricted Stocks Reserved by Wuxi Xiangsheng Medical Technology Co., Ltd. in the 2021 Restricted Stock Incentive Plan- CFi.CN Zhongcai.com

Post date May 10, 2022 — 20:27 Post Lock

Xiangsheng Medical (688358.SH): Granting 163,750 Restricted Shares to 10 Incentive Objects_Stock Information_Market Gold Online

Post date May 10, 2022 — 20:17 Post Lock

Rejing Bio (688068): Announcement on the re-appointment of an accounting firm by Beijing Rejing Biotechnology Co., Ltd.-

Post date April 28, 2022 — 11:50 Post Lock

Xiangsheng Medical: The company's business does not involve direct assisted reproductive technology for the time being

Post date April 25, 2022 — 11:41 Post Lock

Xiangsheng Medical: The company's current production and operation are all normal_ Oriental Fortune Net

Post date April 20, 2022 — 16:58 Post Lock

Xiangsheng Medical: The company's current production and operation are all normal.

Post date April 20, 2022 — 16:56 Post Lock

Xiangsheng Medical: The company's business does not involve direct assisted reproductive technology for the time being_ Oriental Fortune Net

Post date April 20, 2022 — 16:25 Post Lock

Xiangsheng Medical: In 2021, the company has completed the construction investment of the industrialization project of ultrasonic medical imaging equipment and the production capacity of the production line relocation will be greatly improved_Oriental Fortune Network

Post date April 20, 2022 — 16:25 Post Lock

Pacific maintains Xiangsheng Medical's buy rating: Ultrasound revenue maintains a stable growth rate of 20% throughout the year, and 22Q1 revenue increases by 23%.

Post date April 19, 2022 — 18:11 Post Lock

1538 companies announced annual dividend plans_ Oriental Fortune Net

Post date April 19, 2022 — 10:31 Post Lock

33 quarterly reports are good, 7 shares deduct non-net profit more than doubled-CFi.CN Zhongcai Network

Post date April 19, 2022 — 10:27 Post Lock

33 quarterly reports are good, 7 shares deduct non-net profit more than doubled-CFi.CN Zhongcai Network

Post date April 19, 2022 — 07:31 Post Lock

Xiangsheng Medical disclosed that it achieved revenue of 100 million yuan in the first quarter of 2022.

Post date April 19, 2022 — 00:07 Post Lock

Xiangsheng Medical disclosed that it achieved revenue of 100 million yuan in the first quarter of 2022-

Post date April 18, 2022 — 23:23 Post Lock

Xiangsheng Medical (688358.SH) released its 2021 results, with a net profit of 112 million yuan, a year-on-year increase of 12.88% Yahui.com

Post date April 18, 2022 — 21:19 Post Lock

Want to see more data? Registered subscribers can see all the data.